Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSyncona Regulatory News (SYNC)

Share Price Information for Syncona (SYNC)

Share Price is delayed by 15 minutes
Get Live Data
97.00    0.10 (0.10%)
Bid:
97.00
Ask:
97.90
Spread: 0.90 (0.928%)
Market Cap: £589.95m
SYNC Live PriceLast checked at - London Stock Exchange

Intraday Syncona Share Chart

Director Changes

18 Mar 2016 16:59

BACIT LIMITED - Director Changes

BACIT LIMITED - Director Changes

PR Newswire

London, March 18

BACIT Limited (the "Company")

(a closed-ended collective investment scheme established as a company with limited liability under the laws of Guernsey with registered number 55514)

Director Resignation

18 March 2016

The Company announces the resignation of Martin Thomas as a non-executive director of the Company, effective 18 March 2016.

Mr Thomas is chairman of the board of directors of BACIT (UK) Limited, the FCA regulated firm that manages the assets of BACIT Limited. Jeremy Tigue, chairman of BACIT Limited said "Martin has been instrumental in establishing BACIT (UK) Limited having been part of the team that founded BACIT in 2012. His contribution as a director of the fund has been much appreciated, and we look forward to continue working with him as chair of our appointed fund manager in the years to come”.

Company website: www.bacitltd.com

Enquiries:Northern Trust International Fund Administration Services (Guernsey) LimitedEmail: rb235@ntrs.comTel: +44 (0) 1481 745189

Date   Source Headline
11th Nov 20247:00 amRNSAutolus receives US FDA approval
11th Nov 20247:00 amRNSTransaction in Own Shares
8th Nov 20247:00 amRNSTransaction in Own Shares
7th Nov 20247:00 amRNSTransaction in Own Shares
6th Nov 20247:00 amRNSTransaction in Own Shares
5th Nov 20247:00 amRNSTransaction in Own Shares
4th Nov 20247:00 amRNSTransaction in Own Shares
1st Nov 202411:57 amRNSTotal Voting Rights
1st Nov 20247:00 amRNSTransaction in Own Shares
31st Oct 20247:00 amRNSTransaction in Own Shares
30th Oct 20247:00 amRNSTransaction in Own Shares
29th Oct 20247:00 amRNSTransaction in Own Shares
28th Oct 20247:00 amRNSTransaction in Own Shares
25th Oct 20247:00 amRNSTransaction in Own Shares
24th Oct 20247:00 amRNSTransaction in Own Shares
23rd Oct 20247:05 amRNSSpur presents positive data from Phase I/II trial
23rd Oct 20247:00 amRNSTransaction in Own Shares
22nd Oct 20247:00 amRNSTransaction in Own Shares
21st Oct 20247:00 amRNSTransaction in Own Shares
18th Oct 20247:00 amRNSNotice of Results
18th Oct 20247:00 amRNSTransaction in Own Shares
17th Oct 20247:00 amRNSTransaction in Own Shares
16th Oct 20247:00 amRNSTransaction in Own Shares
15th Oct 20243:05 pmRNSBeacon announces positive data from Phase II trial
15th Oct 20247:00 amRNSTransaction in Own Shares
14th Oct 20247:00 amRNSTransaction in Own Shares
11th Oct 20247:00 amRNSTransaction in Own Shares
10th Oct 20247:00 amRNSTransaction in Own Shares
9th Oct 20247:00 amRNSPurespring Therapeutics Series B financing
9th Oct 20247:00 amRNSTransaction in Own Shares
8th Oct 20247:00 amRNSTransaction in Own Shares
7th Oct 20247:00 amRNSTransaction in Own Shares
4th Oct 20247:00 amRNSTransaction in Own Shares
3rd Oct 20247:00 amRNSResolution Series B and new Chair appointment
3rd Oct 20247:00 amRNSTransaction in Own Shares
2nd Oct 20247:00 amRNSTransaction in Own Shares
1st Oct 20242:17 pmRNSTotal Voting Rights
1st Oct 20247:00 amRNSTransaction in Own Shares
30th Sep 20247:00 amRNSTransaction in Own Shares
26th Sep 20247:00 amRNSTransaction in Own Shares
25th Sep 20247:00 amRNSTransaction in Own Shares
24th Sep 20247:00 amRNSTransaction in Own Shares
23rd Sep 20247:00 amRNSTransaction in Own Shares
20th Sep 20247:00 amRNSDirectorate Change
20th Sep 20247:00 amRNSTransaction in Own Shares
19th Sep 20243:00 pmRNSBeacon presents clinical data update
19th Sep 202412:03 pmRNSAchilles announces strategic update
19th Sep 20247:00 amRNSTransaction in Own Shares
18th Sep 20247:00 amRNSTransaction in Own Shares
17th Sep 20247:00 amRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.